Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.59 by 10.69 percent. This is a 18.12 percent increase over earnings of $1.49 per share from the same period last year. The company reported quarterly sales of $193.520 million which beat the analyst consensus estimate of $185.984 million by 4.05 percent. This is a 8.87 percent increase over sales of $177.757 million the same period last year.